This move is archived. Current quotes and coverage live on the stock page.
Get TELY alerts:
TelyRx Holdings Inc. faces a notable decline as market sentiment shifts.
TelyRx Holdings Inc. is experiencing a significant downturn, with its stock price dropping by 3.85% in today’s session to close at CA$2.50. This decline raises concerns among investors about the company’s short-term performance.
Investor takeaway: Investors should remain cautious as TelyRx navigates through a challenging market environment, particularly given its recent financial losses and lack of immediate positive news.
Advertisement
TelyRx Holdings Inc.
TELY.TO
TELY.TO
TelyRx Holdings Inc.
WealthAwesomeMarket cap
$59.83M
52W high
$4.25
52W low
$2.00
1W change
-4.26%
Analyst Price Targets
Based on analyst covering TELY · as of Sep 17, 2026
Wall Street analysts forecast TELY stock price to rise 166.7% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$6.00
+166.7% Upside
Current Price
C$2.25
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on TELY's historical volatility
30-Day Vol
81.3%
Annualized
90-Day Vol
97.6%
Annualized
Trend (90d)
-35.8%
Annualized drift
90d Mean
C$1.98
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$2.16 | C$1.63 – C$2.85 |
| 60 trading days | C$2.07 | C$1.39 – C$3.07 |
| 90 trading days | C$1.98 | C$1.22 – C$3.22 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
TelyRx Holdings Inc. down 3.85% today
The stock's decline reflects broader market concerns and investor sentiment regarding its financial health.
Bull case
Despite the current slide, TelyRx has shown promising revenue growth in its recent quarterly results. This could indicate potential for recovery if the company can effectively manage its losses.
Bear case
The company's net loss of CA$4.7 million in the latest quarter, along with a rising adjusted EBITDA loss, suggests that TelyRx may struggle to maintain investor confidence in the near term.
Current Market Performance
Advertisement
TelyRx Holdings Inc. is facing a challenging market today, with its stock price falling by 3.85%. This decline comes after a recent quarterly report that highlighted an increase in revenue but also a significant net loss. Investors are likely weighing these factors as they consider the company's future prospects.
Financial Health Concerns
The latest financial results revealed that TelyRx’s net loss grew to CA$4.7 million, raising concerns about its profitability. While revenue increased to CA$19.4 million, the rising adjusted EBITDA loss signals potential operational challenges. Investors may want to keep a close eye on how the company addresses these issues moving forward.
Looking Ahead
With TelyRx Holdings Inc. now trading under the symbol TELY on the TSX, the company has entered a new phase following its reverse takeover. However, the current stock slide highlights the importance of monitoring both market sentiment and financial performance closely. Investors should consider the implications of today's decline as they evaluate their positions in TELY.TO.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
